SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-017064
Filing Date
2024-05-15
Accepted
2024-05-15 16:16:27
Documents
50
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbla20240331_10q.htm   iXBRL 10-Q 630557
2 EXHIBIT 31.1 ex_671520.htm EX-31.1 12705
3 EXHIBIT 31.2 ex_671521.htm EX-31.2 13158
4 EXHIBIT 32.1 ex_671522.htm EX-32.1 5948
5 EXHIBIT 32.2 ex_671523.htm EX-32.2 5108
  Complete submission text file 0001437749-24-017064.txt   3137112

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240331.xsd EX-101.SCH 30779
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240331_def.xml EX-101.DEF 208438
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240331_lab.xml EX-101.LAB 190225
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240331_pre.xml EX-101.PRE 227305
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20240331_cal.xml EX-101.CAL 22387
54 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240331_10q_htm.xml XML 318709
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 24951032
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)